Director Global Oncology Medical Affairs, Evidence Generation (m/f/x)

Daiichi Sankyo and its 16,000 employees in more than 20 countries are dedicated to the creation and supply of innovative pharmaceutical products. In Europe, we focus on two areas: In the cardiovascular space, our strong portfolio of medicines reflects our long-standing commitment and shows that we care for every heartbeat; in oncology our goal is to become a global pharma innovator until 2025 by providing novel therapies to patients across the world. Our European headquarters are in Munich, Germany, and we have affiliates in 13 European countries.

The Position:

The Director, Global Oncology Medical Affairs, Evidence Generation role is responsible for co-leading a cross-functional Evidence Generation Team and developing an Integrated Evidence Plan (IEP) for the assigned compound.

Key responsibilities:

• Co-lead a cross-functional Evidence Generation Team (EGT) for the assigned compound in partnership with Global Health Economics & Outcomes Research partner.
• As a member of Global Medical Affairs Team (GMAT, or Joint Medical Affairs Team for Alliance compounds) and as a subject matter expert (SME), in alignment with the GMAT Lead, develop an Integrated Evidence Plan (IEP), which includes an evidence gap assessment, gap prioritization and strategic delivery plan.
• The plan integrates the global/ regional/ country strategies across all relevant functions and aligns with the Disease Area Strategy.
• Communicate progress to relevant internal stakeholders using trackers and tools generated by Global Oncology Medical Affairs Study Operations partners and propose mitigation plans for delayed activities.
• Ensure that appropriate internal and external communication is current and clear.
• Drive the development of Areas of Interest (AOI) for Externally Sponsored Research (ESR).
• Align AOIs with GMAT and GPT.
• Share and discuss the evidence gaps and Integrated Evidence Plans within the team of EG Leads responsible for other compounds within the same Disease Area and with the Disease Area Strategy Leads.
• Serve as a delegate on relevant concept and protocol review committees (within company as well as in the Alliance) for company sponsored and externally sponsored research.

Personal skills and professional experience:

• PharmD or PhD and MD would be required.
• 10 or more Years overall related experience and/or commensurate education/experience.
• 4 or more Years working in a pharmaceutical company in Evidence Generation-related role.
• Experience developing global or regional medical strategy preferably in lung and/or breast cancer.
• Oncology launch preparation and delivery in Global, Regional or Country Medical Affairs.
• Experience planning and conducting Medical Affairs interventional and non-interventional studies, including Ph 3b/4, EAP, externally sponsored research, external clinical collaborations, and observational studies.
• Ability to select the optimal evidence generation activity to fulfill the evidence gap.
• Excellence in collaboration, communication, strategic thinking and achieving alignment in a cross-functional, cross-cultural matrix.
• Ability to influence without authority.
• Results orientation.
• Ability to travel up to 20%.

What we offer

At Daiichi Sankyo in Europe, we offer a workplace where your voice is heard. Everything we do, we do with a high level of commitment and a clear focus on patients' needs. We know that our bold ambition to change patients' lives for the better can only be achieved through the power of collaboration and the exploration of new approaches. Thus, we encourage our colleagues across Europe to be courageous, to bring their ideas to the table and to embrace opportunities to grow. When you join our European family, you will be a part of a dynamic company where everyone, no matter their role, rolls up their sleeves and gets things done.